Trial Profile
Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma: a Prospective, Randomized, Open-label, Phase 2 Study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Etoposide
- Indications Large cell carcinoma; Neuroendocrine carcinoma
- Focus Therapeutic Use
- 27 Oct 2016 New trial record